关于 2025 年第二季度可转换公司债券转股情况公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.蓝晓转 02（债券代码：123195）转股期限为 2023 年 10 月 23 日至 2029 年 4 月 16 日，最新转股价格为人民币 60.28 元/股。 2.2025 年第二季度，共有 38 张"蓝晓转 02"完成转股（票面金额共计 3,800 元人民币），合计转为 62 股"蓝晓科技"股票（股票代码：300487）。 3.截至 2025 年第二季度末，公司剩余可转债为 5,459,660 张，剩余票面总金 额为 545,966,000 元人民币。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司 自律监管指引第 15 号——可转换公司债券》的有关规定，西安蓝晓科技新材料 股份有限公司（以下简称"公司"）现将 2025 年第二季度可转换公司债券（以下 简称"蓝晓转 02"）转股及公司总股本变化情况公告如下： 一、"蓝晓转 02"的基本情况 | 证券代码：300487 | 证券简称：蓝晓科技 | 公告编号：2025-03 ...

| 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2025-030 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转 02 | 西安蓝晓科技新材料股份有限公司 关于实施权益分派期间"蓝晓转 02"暂停转股的 提示性公告 本公司及全体董事会成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者遗漏。 特别提示： 1.债券代码：123195，债券简称：蓝晓转 02 2.转股期限：2023 年 10 月 23 日至 2029 年 4 月 16 日 3.暂停转股时间：2025 年 7 月 1 日至 2024 年度权益分派股权登记日 4.恢复转股时间：2024 年度权益分派股权登记日后的第一个交易日 西安蓝晓科技新材料股份有限公司（以下简称"公司"）将于近日实施 2024 年度权益分派事宜，根据《深圳证券交易所创业板上市公司自律监管指南第 1 号 ——业务办理》及《西安蓝晓科技新材料股份有限公司向不特定对象发行可转换 公司债券募集说明书》中"转股价格的调整方式及计算公式"条款的规定（详见 附件），2025 年 7 月 1 日起至本次权益分派股权登记日止，"蓝晓 ...

证券代码：300487 证券简称：蓝晓科技 债券代码：123195 债券简称：蓝晓转 02 西安蓝晓科技新材料股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为国信证券所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，国信证 券不承担任何责任。 1 第一节 本期债券情况 （2024 年度） 债券受托管理人 （注册地址：深圳市红岭中路 1012 号国信证券大厦 16-26 层） 二零二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称《管理办法》）、 《西安蓝晓科技新材料股份有限公司（发行人）与国信证券股份有限公司（受托 管理人）签订的创业板向不特定对象发行可转换公司债券之受托管理协议》（以 下简称《受托管理协议》）、《西安蓝晓科技新材料股份有限公司创业板向不特 定对象发行可转换公司债券募集说明书》（以下简称《募集说明书》）、《西安 蓝晓科技新材料股份有限公司2024年年度报告》等相关公开信息披露文件、第三 方中介机构出具的专业意见等 ...

Core Viewpoint - The new materials industry is experiencing rapid growth, with significant opportunities arising from technological advancements, policy support, and the need for domestic production capabilities in response to international trade tensions [2][9][13]. Group 1: Industry Overview - The global new materials industry reached a value of $2.8 trillion in 2019, with a competitive landscape divided into three tiers: developed countries in the first tier, rapidly developing countries like China in the second tier, and emerging economies in the third tier [8][12]. - China's new materials industry generated a total output value of 6.4 trillion yuan in 2021, with an average annual growth rate of 23.1% from 2010 to 2021, and is projected to reach 7.5 trillion yuan in 2022 [9][10]. Group 2: Semiconductor Sector - The global semiconductor market was valued at $595 billion in 2021, with expectations to grow to $790 billion by 2026, driven by advancements in 5G and automotive electronics [3][16]. - The semiconductor materials market in China reached $11.9 billion in 2021, growing by 22.2% year-on-year, indicating a significant increase in domestic demand [31][32]. Group 3: Display Materials - The global OLED materials market is expected to grow from approximately $900 million in 2019 to about $2.6 billion by 2024, with a compound annual growth rate (CAGR) of 23.6% [4]. - Domestic companies like Wanrun and Ruile New Materials are leading suppliers in the liquid crystal and OLED material sectors, with significant market shares [4][15]. Group 4: New Energy Materials - The new energy sector is rapidly evolving, with key materials such as composite copper foil, conductive carbon black, and sodium battery materials expected to see substantial market growth [5][15]. - The market for photovoltaic materials is projected to reach 20 billion yuan by 2025, driven by increasing demand for solar energy solutions [15]. Group 5: Environmental Materials - Traditional chemical applications are witnessing upgrades, with domestic companies like Zhongchumai and Jianlong Weina capitalizing on opportunities in molecular sieves and lubricating oil additives [6][15]. - Aerogels, known for their exceptional insulation properties, are gaining traction in construction and electric vehicle markets, with companies like Chenguang New Materials entering this space [6][15].

内部编号:2025060145 2023 年西安蓝晓科技新材料股份有限公司 创业板向不特定对象发行可转换公司债券 定期跟踪评级报告 项目负责人:杨亿 460 m yangyi@shxs j.com 项目组成员:吴晓丽 星 成 Fra wxl@shxsj.com 评级总监:张明海 2-16 联系电话:(021)63501349 联系地址:上海市黄浦区汉口路 398 号华盛大厦 14 层 公司网站：www.shxsj.com 上海新世纪资信评估投资服务有限公司 Shanghai Brilliance Credit Rating & Investors Service Co., Ltd. 声明 除因本次评级事项使本评级机构与评级对象构成委托关系外,本评级机构、评级人员与评级对象不存在任何影响 评级行为独立、客观、公正的关联关系。 本评级机构与评级人员履行了调查和诚信义务,所出具的评级报告遵循了真实、客观、公正的原则。 跟踪评级观点 主要优势: 本报告的评级结论是本评级机构依据合理的内部信用评级标准和程序做出的独立判断,未因评级对象和其他任 何组织或个人的不当影响改变评级意见。 本次跟踪评级依据评级对象及其相关方提供 ...

Group 1: Policy Financial Tools - Historical policy financial tools were introduced as counter-cyclical measures to stabilize the economy and enhance local investment capabilities, characterized by low costs, quick deployment, and market-oriented operations [1][20][21] - New policy financial tools are expected to focus more on technology innovation, consumption, and foreign trade, with significant attention on their scale, leverage effects, and issuance rhythm [1][22] Group 2: Banking Sector - The loan interest rate is expected to decline significantly slower in 2025, with the LPR reform leading to a rapid decline in loan rates during certain periods, but a slowdown is anticipated moving forward [3][31][32] - The banking sector is likely to see a stabilization in performance due to reduced pressure on interest margins, with a recommendation to focus on high-quality regional small banks and stable state-owned banks [3][32] Group 3: Non-Banking Sector - Guoyin Financial Leasing - Guoyin Financial Leasing is projected to achieve total revenue of 28.56 billion yuan in 2024, with a year-on-year growth of 7.2%, and a net profit of 4.5 billion yuan, up 8.5% [3] - The company has seen rapid growth in its ship leasing segment, with revenue reaching 7.7 billion yuan, a year-on-year increase of 32.4% [3] Group 4: Non-Banking Sector - Blue Sky Technology - Blue Sky Technology reported a revenue of 2.554 billion yuan in 2024, a year-on-year increase of 2.6%, with a net profit of 787 million yuan, up 9.8% [24] - The company’s adsorption materials business has shown strong growth, while the lithium extraction project has seen a significant decline in revenue [24][25] Group 5: Non-Banking Sector - Ruile New Materials - Ruile New Materials achieved a revenue of 1.459 billion yuan in 2024, with a year-on-year growth of 20.7%, and a net profit of 252 million yuan, up 87.6% [27] - The display materials segment has become the largest business area for the company, driven by the increasing penetration of OLED panels [27][28][29]

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6]. Core Views - The company reported a revenue of 2.554 billion yuan in 2024, a year-on-year increase of 2.6%, and a net profit attributable to the parent company of 787 million yuan, up 9.8% year-on-year [1]. - The revenue from the lithium extraction project significantly declined, impacting the overall performance of the system equipment segment, while the adsorption materials business showed robust growth [2][3]. - The life sciences segment is expected to continue its growth trajectory, driven by the demand for high-quality solid-phase synthesis carriers and the performance of GLP-1 peptide drugs [3]. Summary by Sections Financial Performance - In Q4 2024, the company achieved a revenue of 662 million yuan, down 27.4% year-on-year, but up 10.89% quarter-on-quarter, with a net profit of 191 million yuan, down 4.0% year-on-year [1]. - For Q1 2025, the company reported a revenue of 577 million yuan, a decrease of 8.6% year-on-year and 12.91% quarter-on-quarter, while the net profit was 193 million yuan, an increase of 14.2% year-on-year [1]. Business Segments - The adsorption materials business generated 1.986 billion yuan in revenue, up 27.61% year-on-year, while the system equipment segment saw a revenue decline of 43.13% to 469 million yuan [2]. - The revenue from the lithium extraction system equipment was only 99 million yuan in 2024, a dramatic drop of 80.96% compared to 520 million yuan in 2023 [2]. Growth Areas - The life sciences segment's revenue reached 568 million yuan in 2024, reflecting a growth of 28% [3]. - The ultra-pure water segment achieved significant breakthroughs, with substantial orders from key semiconductor companies, indicating a growing market presence [3]. Profitability Forecast - The net profit forecasts for 2025-2027 are adjusted to 1.127 billion yuan, 1.463 billion yuan, and 1.706 billion yuan, respectively, maintaining the "Buy" rating [3].

Group 1 - The implementation of new dividend regulations has significantly enhanced the dividend awareness among listed companies in Shaanxi, establishing a stable, timely, and predictable normalization of dividend mechanisms [1] - In 2024, nearly 70% of listed companies in Shaanxi overcame substantial declines in net profits, distributing cash dividends totaling 24.3 billion yuan, maintaining a high level of dividend scale [2] - The overall dividend amount accounted for over 70% of the net profit in the region, a substantial increase of 25 percentage points [2] Group 2 - The dividend payout ratio reached 47% after excluding loss-making companies, reflecting a year-on-year increase of 7 percentage points, indicating a continuous rise in dividend levels [2] - Shaanxi Coal's annual dividend exceeded 13 billion yuan, with a payout ratio close to 60%, setting a benchmark in the Northwest region [2] - In 2024, 36 companies in Shaanxi implemented interim dividends, representing 44% of the total, ranking first in the country [2] Group 3 - Companies such as Shaanxi Coal have maintained cash dividends for five consecutive years, while 11 companies have consistently paid dividends for over ten years, establishing a long-term, stable, and sustainable shareholder return mechanism [3] - Companies are actively improving operations to balance development and returns, as seen with Fenghuo Electronics, which implemented cash dividends and share buybacks after turning its retained earnings positive [3] - Overall, Shaanxi listed companies are responding positively to the new dividend regulations, fulfilling their responsibilities and enhancing investor satisfaction [3]

Core Viewpoint - A legal dispute involving a contract worth 114 million yuan between Bluestar Technology and Sandam Membrane has raised concerns about contract performance risks in the lithium extraction industry chain [2][3]. Group 1: Background of the Dispute - The lawsuit originated from a contract signed in March 2022 for the supply and installation of lithium carbonate adsorption equipment, valued at 114 million yuan, which accounted for 9.54% of Bluestar Technology's 2021 revenue [3]. - Disagreements escalated during the project, leading Bluestar Technology to freeze 58.61 million yuan of Sandam Membrane's assets due to non-payment, prompting Bluestar to file a lawsuit for 47.44 million yuan in contract payments and penalties [3]. - Sandam Membrane counter-sued, claiming Bluestar failed to meet installation deadlines and provided non-compliant equipment, seeking approximately 38.73 million yuan in damages [3]. Group 2: Court Ruling - On May 8, 2025, the court ruled in favor of Bluestar Technology, ordering Sandam Membrane to pay 48.2869 million yuan plus overdue penalties, while dismissing all counterclaims from Sandam [4]. - The court found that Bluestar had fulfilled its contractual obligations, and Sandam's claims regarding delays and equipment quality were unsupported due to insufficient evidence [4]. Group 3: Industry Context - The lawsuit reflects a broader downturn in the lithium extraction industry, where lithium carbonate prices plummeted from 590,000 yuan per ton in 2022 to around 65,000 yuan per ton in 2023, leading to project viability concerns [5]. - The industry is facing prolonged overcapacity and extended expansion cycles due to falling prices [5]. Group 4: Financial Impact - The ongoing litigation has materially affected the financial health of both companies. Bluestar Technology's revenue from lithium extraction systems dropped to 99 million yuan in 2024, a decline attributed to project confirmation delays [7]. - Sandam Membrane is experiencing severe cash flow issues, with a 78.38% year-on-year decline in net cash flow from operating activities, amounting to 12.1899 million yuan in Q1 2025 [7]. - Additionally, Sandam is facing further financial strain from another arbitration case involving 34.09 million yuan [7]. Group 5: Future Implications - Sandam Membrane plans to appeal the ruling, which could lead to a second trial. A favorable outcome for Bluestar could help confirm project revenues and alleviate financial pressures, while a successful appeal for Sandam could mitigate losses [8]. - The dispute highlights the need for clearer risk-sharing mechanisms and enhanced compliance monitoring in the lithium extraction industry to ensure healthy future development [8].

Group 1: Financial Performance - In 2024, the revenue from the system device business increased by 85%, but installation and debugging costs accounted for over 25% of the revenue [4] - The revenue from the life sciences sector reached 5.68 billion yuan, with a growth rate of 28% [14] - The revenue from the water treatment and ultrapure water business grew by 20%, with a total revenue of 6.88 billion yuan [7] Group 2: Operational Efficiency - The inventory turnover days extended to 180 days due to increased stock of system devices [4] - The company aims to reduce work-in-progress inventory by 25% through digital twin technology optimization [4] - The company achieved a 5-fold increase in inspection efficiency by replacing manual visual inspection with AI visual detection [3] Group 3: Market Expansion and Strategy - In 2024, overseas revenue accounted for 38% of total revenue, amounting to 6.55 billion yuan [10] - The company plans to enhance market development efficiency through the release of industry solution white papers covering six major fields [5] - The life sciences sector's revenue share increased to 29%, with a focus on new product development in peptide synthesis [5] Group 4: Research and Development - The R&D investment intensity reached 9.8%, but the patent implementation rate was below 45% [9] - The company holds 66 domestic and 13 foreign authorized patents, with 74 domestic and 103 foreign patents in the application stage [9] - The company is focusing on developing new types of polyethylene glycol carriers to increase drug loading capacity by 20% [5] Group 5: Supply Chain and Risk Management - The company reported no supply chain security challenges, with most raw materials already localized [12] - The accounts receivable turnover days extended to 125 days, with 65% of accounts receivable from system device projects [10] - The company is exploring credit insurance to cover 80% of accounts receivable to improve cash flow [10]